Results: 2

1.
Fig 2.

Fig 2. From: Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms.

Acute myeloid leukemia (AML) survival in relation to previous therapy. Mixed combinations of two to three cytoreductive treatments (n = 46), alkylators only (n = 21), none (n = 47), hydroxyurea (HydroxyU) only (n = 45), and radioactive phosphorous (P32) only (n = 47).

Magnus Björkholm, et al. J Clin Oncol. 2011 June 10;29(17):2410-2415.
2.
Fig 1.

Fig 1. From: Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms.

Risk of acute myeloid leukemia (AML) transformation in relation to time since myeloproliferative neoplasm (MPN) diagnosis according to subtype. Determined for all patients with MPNs with AML transformation who were identified from the Swedish Cancer Registry (n = 235). ET, essential thrombocythemia; NOS, not otherwise specified; PMF, primary myelofibrosis; PV, polycythemia vera.

Magnus Björkholm, et al. J Clin Oncol. 2011 June 10;29(17):2410-2415.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk